Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets. (Q53230721)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 September 2014

Language	Label	Description	Also known as
English	Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets.	scientific article published on 16 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

microRNA expression

0 references

malignant pleural mesothelioma

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Eric G Ramírez-Salazar

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Luis Carlos Salinas-Silva

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Maria Eugenia Vázquez-Manríquez

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Luis Vicente Gayosso-Gómez

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Maria Cristina Negrete-Garcia

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sandra Lizbeth Ramírez-Rodriguez

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Raúl Chávez

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Patricio Santillán

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Javier Kelly-García

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Blanca Ortiz-Quintero

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

16 September 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

97

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

375-385

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236577%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MicroRNAs: target recognition and regulatory functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MIQE précis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Origins and Mechanisms of miRNAs and siRNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Multidisciplinary treatment of malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

NSAIDs and cancer prevention: targets downstream of COX-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MAP kinase signalling pathways in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Roles for microRNAs in conferring robustness to biological processes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

ETS-1 oncogenic activity mediated by transforming growth factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Review on clinical trials of targeted treatments in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Molecular changes in mesothelioma with an impact on prognosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Current concepts in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Histone demethylase retinoblastoma binding protein 2 is overexpressed in hepatocellular carcinoma and negatively regulated by hsa-miR-212.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Evolution of microRNA expression during human bronchial squamous carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

A novel and universal method for microRNA RT-qPCR data normalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MicroRNA-155 is induced during the macrophage inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

microRNA regulation of inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MicroRNAs and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Malignant pleural mesothelioma: an update on biomarkers and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Analyzing biological network parameters with CentiScaPe

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Molecular pathogenesis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Inflammation and necrosis promote tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Up-regulated MicroRNA-181a induces carcinogenesis in hepatitis B virus-related hepatocellular carcinoma by targeting E2F5

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.09.016

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53230721&oldid=1505990489"